Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compositions and methods for targeting MASAs to treat cancers with spliceosome mutations

US Patent 12098172 · Granted Sep 24, 2024

Estimated economic value: $82,231,000

Assignee

Inventors

View full patent text on Google Patents →